Life sciences job openings · Updated 2026-07-24
Parabilis Medicines Launches $670M IPO with $20 Share Price
Biopharma IPOs Rebound with $1.8B in Q1 2026, Median Deal Soars to $287.5M
News sourced from public life sciences media. Not affiliated with these publications.
Company description, mission, culture, and benefits — visible after this page is claimed and verified.
Sign up free to search all 10+ openings with AI-powered matching.
Search Parabilis Medicines JobsProfile generated from publicly available hiring data.
·Are you Parabilis Medicines? Claim this page or contact us